{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T17:11:36Z","timestamp":1768929096285,"version":"3.49.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Gouty arthritis is a frequent and disabling complication in heart failure patients. This study aimed to investigate which factors are associated with the occurrence of gouty arthritis in these patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A case\u2013control study was performed in heart failure patients (February 2007 to October 2009). Cases were defined as patients with gouty arthritis. Factors that are possibly associated with gouty arthritis and\/or heart failure were evaluated. Echocardiographic dimensions and laboratory values including glomerular filtration rate (GFR) and fractional excretion of uric acid (FEUA) were measured. Logistic regression analysis was used to determine crude and adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for possibly associated factors. In total, 188 patients (59 with gouty arthritis) were included. Spironolactone use was associated with a decreased occurrence of gouty arthritis (OR 0.32, 95% CI 0.13\u20130.77). Independently associated with an increased occurrence of gouty arthritis were hypertensive heart failure (OR 3.6, 95% CI 1.6\u20138.2), New York Heart Association (NYHA) class III\/IV (OR 4.5, 95% CI 1.8\u201311.0), lower GFR (P &amp;lt; 0.001), and FEUA &amp;lt;4% (OR 3.3, 95% CI 1.4\u20137.9). Among the four age\/gender groups, the strongest association with gouty arthritis was found in men &amp;lt;65 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our identification of factors that are associated with the occurrence of gouty arthritis makes it possible to develop strategies to improve further the quality of life in heart failure patients. The possible decreased occurrence of gouty arthritis in spironolactone users has to be confirmed in prospective studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjhf\/hfs086","type":"journal-article","created":{"date-parts":[[2012,6,22]],"date-time":"2012-06-22T12:13:16Z","timestamp":1340367196000},"page":"916-921","source":"Crossref","is-referenced-by-count":9,"title":["A Case\u2013Control Study of Determinants for the Occurrence of Gouty Arthritis in Heart Failure Patients"],"prefix":"10.1093","volume":"14","author":[{"given":"Berdine A.A.","family":"Hueskes","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Rijnstate, 6883 AZ Velp \u00a0","place":["The Netherlands"]},{"name":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences , Utrecht ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank F.","family":"Willems","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rijnstate , Arnhem ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aukelien C.","family":"Leen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rijnstate , Arnhem ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia A.","family":"Ninaber","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rijnstate , Arnhem ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Westra","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Scheperziekenhuis , Emmen ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aukje K.","family":"Mantel-Teeuwisse","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences , Utrecht ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hein J.E.M.","family":"Janssens","sequence":"additional","affiliation":[{"name":"Department of Primary and Community Care, Radboud University Nijmegen Medical Centre , Nijmegen ,","place":["The Netherlands"]},{"name":"Primary Care Health Centre Lobede , Lobith-Tolkamer ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eloy H.","family":"van de Lisdonk","sequence":"additional","affiliation":[{"name":"Department of Primary and Community Care, Radboud University Nijmegen Medical Centre , Nijmegen ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth A.","family":"Roovers","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, Rijnstate , Arnhem ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthijs","family":"Janssen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Rijnstate, 6883 AZ Velp \u00a0","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,2,18]]},"reference":[{"key":"2026011921173853700_ejhfhfs086-bib-0001","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMcp1001124","article-title":"Clinical practice. Gout","volume":"364","author":"Neogi","year":"2011","journal-title":"N Engl J Med"},{"key":"2026011921173853700_ejhfhfs086-bib-0002","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ejheart.2008.02.009","article-title":"Chronic heart failure, selected risk factors and co-morbidities among adults treated for hypertension in a cardiac referral hospital in Cameroon","volume":"10","author":"Dzudie","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"2026011921173853700_ejhfhfs086-bib-0003","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/ard.2005.040360","article-title":"Gout, not induced by diuretics? A case\u2013control study from primary care","volume":"65","author":"Janssens","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2026011921173853700_ejhfhfs086-bib-0004","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1681\/ASN.2007111256","article-title":"Association of incident gout and mortality in dialysis patients","volume":"19","author":"Cohen","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"2026011921173853700_ejhfhfs086-bib-0005","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/art.23575","article-title":"Validation of the Health Assessment Questionnaire disability index in patients with gout","volume":"59","author":"\u00c1lvarez-Hern\u00e1ndez","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2026011921173853700_ejhfhfs086-bib-0006","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"2026011921173853700_ejhfhfs086-bib-0007","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"2026011921173853700_ejhfhfs086-bib-0008","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/eurjhf\/hfp175","article-title":"Heart failure registry: a valuable tool for improving the management of patients with heart failure","volume":"12","author":"Jonsson","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2026011921173853700_ejhfhfs086-bib-0009","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archinte.162.3.265","article-title":"Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study","volume":"162","author":"Feenstra","year":"2002","journal-title":"Arch Intern Med."},{"key":"2026011921173853700_ejhfhfs086-bib-0010","first-page":"801","article-title":"Gout: an update","volume":"76","author":"Eggebeen","year":"2007","journal-title":"Am Fam Physician"},{"key":"2026011921173853700_ejhfhfs086-bib-0011","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00265-008-0683-4","article-title":"Distribution-free two-sample comparisons in the case of heterogeneous variances","volume":"63","author":"Neuhauser","year":"2009","journal-title":"Behav Ecol Sociobiol"},{"key":"2026011921173853700_ejhfhfs086-bib-0012","author":"R Development Core Team R: a language and Environment for Statistical Computing","year":"2009"},{"key":"2026011921173853700_ejhfhfs086-bib-0013","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/bmj.1.6158.224","article-title":"Comparison of natriuretic, uricosuric, and antihypertensive properties of tienilic acid, bendrofluazide, and spironolactone","volume":"1","author":"Roberts","year":"1979","journal-title":"BMJ"},{"key":"2026011921173853700_ejhfhfs086-bib-0014","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0960-0760(90)90484-3","article-title":"Antiandrogens: clinical applications","volume":"37","author":"Sciarra","year":"1990","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2026011921173853700_ejhfhfs086-bib-0015","doi-asserted-by":"crossref","first-page":"398","DOI":"10.7326\/0003-4819-87-4-398","article-title":"Pathophysiology of spironolactone-induced gynecomastia","volume":"87","author":"Rose","year":"1977","journal-title":"Ann Intern Med"},{"key":"2026011921173853700_ejhfhfs086-bib-0016","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar1907","article-title":"Epidemiology, risk factors, and lifestyle modifications for gout","volume":"8","author":"Saag","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"2026011921173853700_ejhfhfs086-bib-0017","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/rheumatology\/24.2.155","article-title":"Diuretic-induced gout in elderly women","volume":"24","author":"Macfarlane","year":"1985","journal-title":"Br J Rheumatol"},{"key":"2026011921173853700_ejhfhfs086-bib-0018","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3109\/10641960902929438","article-title":"Spironolactone and chlorthalidone in uncontrolled elderly hypertensive patients treated with calcium antagonists and angiotensin II receptor-blocker: effects on endothelial function, inflammation, and oxidative stress","volume":"31","author":"Yamanari","year":"2009","journal-title":"Clin Exp Hypertens"},{"key":"2026011921173853700_ejhfhfs086-bib-0019","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00296-009-1304-x","article-title":"Prevalence of insulin resistance and metabolic syndrome in patients with gouty arthritis","volume":"31","author":"Yoo","year":"2011","journal-title":"Rheumatol Int"},{"key":"2026011921173853700_ejhfhfs086-bib-0020","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/art.23121","article-title":"Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study","volume":"58","author":"Ioachimescu","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2026011921173853700_ejhfhfs086-bib-0021","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/eurjhf\/hfr030","article-title":"Predictors of clinical outcomes in elderly patients with heart failure","volume":"13","author":"Manzano","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026011921173853700_ejhfhfs086-bib-0022","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archinte.165.7.742","article-title":"Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study","volume":"165","author":"Choi","year":"2005","journal-title":"Arch Intern Med"},{"key":"2026011921173853700_ejhfhfs086-bib-0023","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/sj.jhh.1000496","article-title":"Incidence of diabetes and gout in hypertensive patients during 8 years of follow-up. The General Practice Hypertension Study Group","volume":"11","author":"Grodzicki","year":"1997","journal-title":"J Hum Hypertens"},{"key":"2026011921173853700_ejhfhfs086-bib-0024","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N Engl J Med"},{"key":"2026011921173853700_ejhfhfs086-bib-0025","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.3949\/ccjm.75.Suppl_5.S13","article-title":"The role of hyperuricemia and gout in kidney and cardiovascular disease","volume":"75","author":"Edwards","year":"2008","journal-title":"Cleve Clin J Med"},{"key":"2026011921173853700_ejhfhfs086-bib-0026","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMra000050","article-title":"Aldosterone in congestive heart failure","volume":"345","author":"Weber","year":"2001","journal-title":"N Engl J Med"},{"key":"2026011921173853700_ejhfhfs086-bib-0027","first-page":"43","article-title":"High prevalence of gout in patients with Type 2 diabetes: male sex, renal impairment, and diuretic use are major risk factors","volume":"121","author":"Suppiah","year":"2008","journal-title":"N Z Med J"},{"key":"2026011921173853700_ejhfhfs086-bib-0028","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1440-1797.2006.00577.x","article-title":"Gout in renal transplant recipients","volume":"11","author":"Stamp","year":"2006","journal-title":"Nephrology"},{"key":"2026011921173853700_ejhfhfs086-bib-0029","doi-asserted-by":"crossref","first-page":"R177","DOI":"10.1093\/hmg\/ddp369","article-title":"Recent insights into the pathogenesis of hyperuricaemia and gout","volume":"18","author":"Riches","year":"2009","journal-title":"Hum Mol Genet"},{"key":"2026011921173853700_ejhfhfs086-bib-0030","first-page":"1341","article-title":"Recent diuretic use and the risk of recurrent gout attacks: the online case-crossover gout study","volume":"33","author":"Hunter","year":"2006","journal-title":"J Rheumatol"},{"key":"2026011921173853700_ejhfhfs086-bib-0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2011.11.008","article-title":"Use of diuretics and the risk of gouty arthritis: a systematic review","author":"Hueskes","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"2026011921173853700_ejhfhfs086-bib-0032","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2008.05.022","article-title":"Uric acid: a marker of increased cardiovascular risk","volume":"202","author":"Gagliardi","year":"2009","journal-title":"Atherosclerosis"},{"key":"2026011921173853700_ejhfhfs086-bib-0033","first-page":"16","article-title":"Uric acid: a risk factor for coronary atherosclerosis?","volume":"18","author":"Hashemi","year":"2007","journal-title":"Cardiovasc J S Afr"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1093%2Feurjhf%2Fhfs086","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/14\/8\/916\/66442431\/eurjhf_14_8_916.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/14\/8\/916\/66442431\/eurjhf_14_8_916.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:23:14Z","timestamp":1768875794000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/14\/8\/916\/8428912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,1]]},"references-count":33,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,2,18]]},"published-print":{"date-parts":[[2012,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjhf\/hfs086","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,8]]},"published":{"date-parts":[[2012,8,1]]}}}